"overlooking that his own invested company was approved in...

First 499 Last

Share
Profile

Follow
Blinger

216 Posts.

35

17/06/24

19:46

Post #: 74358095
Share

Originally posted by bedger: ↑

There was a comma in there. I was discussing various types of stem cells and you picked out a small ambiquitiy in grammar? Amongst all the ignorant crap that is being incorrectly written about stem cells on here, that I am trying to correct with solid links on research (even FDA research in IPSC's that clearly many ignorant of) and evidence?

No, for clarity Pfeifer, whilst the FDA has approved various autologous stem cells, including chondrocytes, but mainly hematopoietic stem cells and not allogeneic, unless you count Omisirge (omidubicel), and yes, not autlogoous Mesenchymal either. But you might count Chondron, mixing chondrons with allogeneic stem cells in South Korea, or Kaloderm, an allogeneic epidermal cell treatment as 'global approvals'.

And to be a stickler, there has actually been a global approval in an autologous mesenchymal stem cell treatments - unless peopel were to racistly dismiss it - Cupistem, a cultured autologous, adipose-derived mesenchymal stem cell treatment in South Korea.

You may notice above I was citing hematopoietic stem cells above as the exception, for specifically the FDA, until one of our trolls incorrectly dismissed all types of stem cells approvals globally, overlooking that his own invested company was approved in Mesenchymal in three continents.

Fighting the trolls is hard enough (our other one busy disproving his own perverse point that the FDA not courting Cynata or IPSC's some deviation from their normal behaviour as some QED moment for him) without doing battle with you too.

Expand

"overlooking that his own invested company was approved in Mesenchymal in three continents."

Agree, an obvious uppercut there.
Maybe SI can also come up with an indication for punch drunks? in short order no doubt!!

CYP Price at posting: 26.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

I88

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Investor education equals superior returns

HotCopper Trends: Final day of quarterlies; Larvotto FID & more

LRV

Larvotto hits "go" on Hillgrove Project

SS1

Sun Silver unveils Maverick Springs assay results

First 499 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 15.5¢		Change -0.015(8.82%)		Mkt cap ! $35.58M

Open	High	Low	Value	Volume
17.0¢	17.0¢	15.5¢	$35.01K	213.1K

Buyers (Bids)

No.	Vol.	Price($)
4	201289	15.5¢

Sellers (Offers)

Price($)	Vol.	No.
16.5¢	14675	1

View Market Depth

No.	Vol.	Price($)
4	201289	0.155
7	323545	0.150
4	81775	0.145
5	315005	0.140
1	5000	0.130

Price($)	Vol.	No.
0.165	14675	1
0.170	26942	1
0.175	94733	3
0.180	168521	4
0.185	29378	3

Last trade - 16.10pm 31/07/2025 (20 minute delay)

CYP (ASX) Chart

"overlooking that his own invested company was approved in...

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Investor education equals superior returns

HotCopper Trends: Final day of quarterlies; Larvotto FID & more

Larvotto hits "go" on Hillgrove Project

Sun Silver unveils Maverick Springs assay results

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

"overlooking that his own invested company was approved in...

Top Stories

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Investor education equals superior returns

HotCopper Trends: Final day of quarterlies; Larvotto FID & more

Larvotto hits "go" on Hillgrove Project

Sun Silver unveils Maverick Springs assay results

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News